Benitec Biopharma (BNTC) Invested Capital (2019 - 2025)
Historic Invested Capital for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $317.7 million.
- Benitec Biopharma's Invested Capital rose 266221.74% to $317.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $317.7 million, marking a year-over-year increase of 266221.74%. This contributed to the annual value of $47.2 million for FY2024, which is 2329009.9% up from last year.
- Per Benitec Biopharma's latest filing, its Invested Capital stood at $317.7 million for Q1 2025, which was up 266221.74% from $281.5 million recorded in Q4 2024.
- Benitec Biopharma's Invested Capital's 5-year high stood at $317.7 million during Q1 2025, with a 5-year trough of $202000.0 in Q2 2023.
- Over the past 5 years, Benitec Biopharma's median Invested Capital value was $14.6 million (recorded in 2022), while the average stood at $50.4 million.
- Its Invested Capital has fluctuated over the past 5 years, first crashed by 9299.1% in 2023, then surged by 2329009.9% in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's Invested Capital stood at $10.8 million in 2021, then dropped by 17.0% to $9.0 million in 2022, then soared by 72.0% to $15.5 million in 2023, then skyrocketed by 1719.64% to $281.5 million in 2024, then increased by 12.84% to $317.7 million in 2025.
- Its Invested Capital stands at $317.7 million for Q1 2025, versus $281.5 million for Q4 2024 and $64.2 million for Q3 2024.